Trial · NCT03005288
Results by group45
Each measurement the trial posted, group by group, in the words and numbers it posted.
21 to 40 of 45
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Body Mass Index (BMI) | Placebo | week 24 | -0.17 | 80% Confidence Interval -0.43 to 0.10 | Kg/m^2 |
| Change From Baseline in Body Mass Index (BMI) | BYM338 10 mg/kg | week 48 | -2.19 | 80% Confidence Interval -2.60 to -1.78 | Kg/m^2 |
| Change From Baseline in Body Mass Index (BMI) | Placebo | week 48 | -0.28 | 80% Confidence Interval -0.67 to 0.11 | Kg/m^2 |
| Change From Baseline in Weight | BYM338 10 mg/kg | week 24 | -3.99 | 80% Confidence Interval -4.79 to -3.19 | Kg |
| Change From Baseline in Weight | Placebo | week 24 | -0.57 | 80% Confidence Interval -1.34 to 0.21 | Kg |
| Change From Baseline in Weight | BYM338 10 mg/kg | week 48 | -5.90 | 80% Confidence Interval -7.08 to -4.71 | Kg |
| Change From Baseline in Weight | Placebo | week 48 | -0.79 | 80% Confidence Interval -1.92 to 0.33 | Kg |
| Change From Baseline in Lean Body Mass (LBM) Measured by DXA | BYM338 10 mg/kg | week 24 | 1.72 | 80% Confidence Interval 1.25 to 2.19 | Kg |
| Change From Baseline in Lean Body Mass (LBM) Measured by DXA | Placebo | week 24 | 0.23 | 80% Confidence Interval -0.23 to 0.68 | Kg |
| Change From Baseline in Lean Body Mass (LBM) Measured by DXA | BYM338 10 mg/kg | week 48 | 1.70 | 80% Confidence Interval 1.14 to 2.26 | Kg |
| Change From Baseline in Lean Body Mass (LBM) Measured by DXA | Placebo | week 48 | -0.44 | 80% Confidence Interval -0.97 to 0.09 | Kg |
| Change From Baseline in Waist Circumference | BYM338 10 mg/kg | week 24 | -5.04 | 80% Confidence Interval -5.87 to -4.20 | cm |
| Change From Baseline in Waist Circumference | Placebo | week 24 | -0.95 | 80% Confidence Interval -1.75 to -0.14 | cm |
| Change From Baseline in Waist Circumference | BYM338 10 mg/kg | week 52 | -9.00 | 80% Confidence Interval -10.3 to -7.68 | cm |
| Change From Baseline in Waist Circumference | Placebo | week 52 | 0.45 | 80% Confidence Interval -0.79 to 1.69 | cm |
| Change From Baseline in Waist to Hip Ratio | BYM338 10 mg/kg | week 24 | -0.02 | 80% Confidence Interval -0.03 to -0.01 | ratio |
| Change From Baseline in Waist to Hip Ratio | Placebo | week 24 | -0.01 | 80% Confidence Interval -0.01 to 0.00 | ratio |
| Change From Baseline in Waist to Hip Ratio | BYM338 10 mg/kg | week 52 | -0.05 | 80% Confidence Interval -0.06 to -0.04 | ratio |
| Change From Baseline in Waist to Hip Ratio | Placebo | week 52 | 0.01 | 80% Confidence Interval 0.00 to 0.02 | ratio |
| Change From Baseline in Insulin Resistance (HOMA2-IR) | BYM338 10 mg/kg | week 12 | 0.10 | 80% Confidence Interval -0.17 to 0.37 | Insulin Resistance (IR) Score |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03005288/results?page=2